USPTO serial 87381007
MEITHEAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 17, 2021
- Examiner
- WRIGHT, LAURA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MEITHEAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Meitheal Pharmaceuticals, Inc.
Chicago, IL, US
Meitheal Pharmaceuticals, Inc.
Des Plaines, IL, US
Meitheal Pharmaceuticals, Inc.
Chicago, IL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eric R. Moran
Eric R. Moran MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP300 SOUTH WACKER DRIVE31ST FLOORCHICAGO, IL 60606-6709Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | antibacterial pharmaceutical preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of diseases of the skin and subcutaneous tissue; pharmaceutical preparations for the treatment of diseases of the digestive system; pharmaceutical preparations for the treatment of diseases of the genitourinary system; muscle relaxants; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; vitamin D analogs; pharmaceutical preparations for the treatment of endocrine diseases; anticoagulants; pharmaceutical preparations for the treatment of diseases of the circulatory system; antiemetics; pharmaceutical preparations for the treatment of nausea; pharmaceutical preparations for hormone therapy; anticholinergics; pharmaceutical preparations for use in connection with anesthesia; pharmaceutical preparations for the treatment of gastrointestinal ailments; pharmaceutical preparations for the treatment of heart rhythm disorders; vasodilators; inotropes; immunosuppressants; pharmaceutical preparations for use in connection with organ transplants; vasoconstrictors; decongestants; beta-lactamase inhibitors | ACTIVE | Oct 6, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Meitheal Pharmaceuticals, Inc.
- Other trademarks owned by Meitheal Pharmaceuticals, Inc.
- Other trademarks owned by Meitheal Pharmaceuticals, Inc.
- Other trademarks in Class 005
- Similar marks named MEITHEAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 17, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 17, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 16, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 15, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 29, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 21, 2021 | IUAF | USE AMENDMENT FILED | — |
| May 21, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 5, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 4, 2021 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 20, 2020 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 20, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 26, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 22, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 22, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 22, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 26, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 22, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 22, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 22, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 15, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 13, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 13, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 13, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 21, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 19, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 19, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 19, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 20, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 20, 2018 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 22, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 27, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 27, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 7, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 22, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 6, 2018 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Feb 6, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 5, 2018 | IROA | RESPONSE TO ITU OFFICE ACTION ENTERED | — |
| Feb 5, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 2, 2018 | INCD | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST | — |
| Feb 2, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 15, 2018 | ALIE | ASSIGNED TO LIE | — |
| Dec 28, 2017 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Dec 28, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 28, 2017 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Dec 28, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 27, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 25, 2017 | NWAP | NEW APPLICATION ENTERED | — |